Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS
- PMID: 12855558
- DOI: 10.1182/blood-2003-04-1027
Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS
Abstract
Bcl2's antiapoptotic function is regulated by phosphorylation. Bcl2 also regulates cell cycle progression, but the molecular mechanism is unclear. Bcl2 is functionally expressed in mitochondria where it can act as an antioxidant that may regulate intracellular reactive oxygen species (ROS). Since ROS have been reported to act as second messengers in cell signaling, we tested whether Bcl2 phosphorylation regulates ROS and cell cycle progression. G1 --> S transition and ROS levels were measured in cells expressing either the gain of function phosphomimetic Bcl2 mutants S70E and T69E/S70E/S87E (EEE) or the nonphosphorylatable and survival-deficient mutants S70A and T69A/S70A/S87A (AAA). Expression of S70E and EEE but not the A-containing Bcl2 mutants retards G1 --> S transition by 35% to 50% and significantly slows cell growth in association with reduced levels of intracellular ROS. In addition to expression of the phosphomimetic Bcl2 mutants, either interleukin-3 withdrawal or treatment of cells with the antioxidant pyrrolidine dithiocarbamate (PDTC) also reduces intracellular ROS levels in association with up-regulation of p27 and accumulation of cells in G0/G1. Retardation of G1 --> S transition can be overridden by directly adding H2O2 to the cells in a mechanism that involves down-regulation of p27 and activation of Cdk2. Thus, Bcl2 may regulate G1 --> S transition by a novel signaling mechanism that couples regulation of intracellular ROS with p27 and Cdk2. Furthermore, phosphorylation of Bcl2 may functionally link its antiapoptotic, cell cycle retardation, and antioxidant properties.
Similar articles
-
Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions.Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):153-8. doi: 10.1073/pnas.2533920100. Epub 2003 Dec 5. Proc Natl Acad Sci U S A. 2004. PMID: 14660795 Free PMC article.
-
Bcl2's flexible loop domain regulates p53 binding and survival.Mol Cell Biol. 2006 Jun;26(12):4421-34. doi: 10.1128/MCB.01647-05. Mol Cell Biol. 2006. PMID: 16738310 Free PMC article.
-
BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.Oncogene. 2002 Nov 7;21(51):7765-75. doi: 10.1038/sj.onc.1205928. Oncogene. 2002. PMID: 12420213
-
The cell cycle is a redox cycle: linking phase-specific targets to cell fate.Free Radic Biol Med. 2009 Nov 1;47(9):1282-93. doi: 10.1016/j.freeradbiomed.2009.05.026. Epub 2009 May 29. Free Radic Biol Med. 2009. PMID: 19486941 Review.
-
Functional Roles of DYRK2 as a Tumor Regulator.Curr Issues Mol Biol. 2023 Oct 23;45(10):8539-8551. doi: 10.3390/cimb45100538. Curr Issues Mol Biol. 2023. PMID: 37886981 Free PMC article. Review.
Cited by
-
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.Am J Pathol. 2004 Jul;165(1):159-66. doi: 10.1016/s0002-9440(10)63284-1. Am J Pathol. 2004. PMID: 15215171 Free PMC article.
-
Arecoline downregulates levels of p21 and p27 through the reactive oxygen species/mTOR complex 1 pathway and may contribute to oral squamous cell carcinoma.Cancer Sci. 2012 Jul;103(7):1221-9. doi: 10.1111/j.1349-7006.2012.02294.x. Epub 2012 May 25. Cancer Sci. 2012. PMID: 22469187 Free PMC article.
-
High-Dose Dexmedetomidine Promotes Apoptosis in Fetal Rat Hippocampal Neurons.Drug Des Devel Ther. 2021 Jun 8;15:2433-2444. doi: 10.2147/DDDT.S300247. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34135573 Free PMC article.
-
Systems analysis of phosphorylation-regulated Bcl-2 interactions establishes a model to reconcile the controversy over the significance of Bcl-2 phosphorylation.Br J Pharmacol. 2019 Feb;176(3):491-504. doi: 10.1111/bph.14555. Epub 2018 Dec 26. Br J Pharmacol. 2019. PMID: 30500985 Free PMC article.
-
Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation.Cancers (Basel). 2020 Mar 30;12(4):831. doi: 10.3390/cancers12040831. Cancers (Basel). 2020. PMID: 32235588 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases